Denmark has a long tradition for strong public-private partnerships.
Public-private partnerships are seen as a key to address the rising demands for healthcare services, caused by longer life expectancy, the increase in chronic diseases, and the more expensive treatments available. The close collaboration between the pharmaceutical companies and the public healthcare system is important to secure new and innovative medicine for the patients.
